At KBI Global Investors, we have a strong commitment to addressing climate change issues, having launched our Energy Solutions equity strategy as far back as 2001. We are committed to TCFD reporting, and have already opted in to the voluntary TCFD reporting module of the PRI.
KBIGI’s Energy Solutions strategy, which has been managed by the firm since its inception in 2000, invests only in companies whose products or services are contributing to a climate-neutral economy and society, via renewable energy and energy efficiency investments.
Other Sustainable Natural Resources portfolios are supportive of net-zero emissions, including our Sustainable Infrastructure strategy which allocates capital towards investments in companies which are building or maintaining sustainable infrastructure in the areas of clean energy, clean water, and safe food.
We launched our Energy Solutions strategy, investing in renewable energy and energy efficiency companies around the globe, as long ago as 2001, so we have a self-evident long-standing commitment to addressing climate change.
We are members of the Principles for Responsible Investments (since 2008), the Investor Decarbonisation Initiative which promotes the adoption of Science-Based Targets, the CDP, and several other organisations and initiatives.
AstraZeneca is a global, science-led biopharmaceutical company. We discover, develop and commercialise prescription medicines.
Nano Energies is trading electricity in a sustainable way. It is active in six spot markets across Europe, where it strives to make energy flows more efficient.